These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8971740)

  • 21. 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission.
    Parsons LH; Kerr TM; Tecott LH
    J Neurochem; 2001 Apr; 77(2):607-17. PubMed ID: 11299323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.
    Dawson LA; Nguyen HQ
    Eur J Pharmacol; 1998 Mar; 345(1):41-6. PubMed ID: 9593592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice.
    Malagié I; David DJ; Jolliet P; Hen R; Bourin M; Gardier AM
    Eur J Pharmacol; 2002 May; 443(1-3):99-104. PubMed ID: 12044798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?
    Beyer CE; Cremers TI
    Eur J Pharmacol; 2008 Feb; 580(3):350-4. PubMed ID: 18177637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study.
    Malagié I; Trillat AC; Jacquot C; Gardier AM
    Eur J Pharmacol; 1995 Nov; 286(2):213-7. PubMed ID: 8605960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
    Gundlah C; Hjorth S; Auerbach SB
    Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C; Boyd DF; Middlemiss DN; Routledge C
    Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
    Zhou FC; McKinzie DL; Patel TD; Lumeng L; Li TK
    Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ].
    Gardier AM; Trillat AC; Malagié I; David D; Hascoët M; Colombel MC; Jolliet P; Jacquot C; Hen R; Bourin M
    C R Acad Sci III; 2001 May; 324(5):433-41. PubMed ID: 11417564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.
    Romero L; Hervás I; Artigas F
    Neurosci Lett; 1996 Nov; 219(2):123-6. PubMed ID: 8971795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
    Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
    J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
    Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A
    Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.